TLX fundamentals
An in-depth look to Telix Pharmaceuticals Limited operating, investing, and financing activities
TLX free cash flow for H1 24 is 19.89 M USD. For 2023, TLX free cash flow was 9.43 M USD and operating cash flow was 15.85 M USD.
Q1 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '24
TTM